KR810001073B1 - Process for preparing spirobenzofuranone compounds - Google Patents

Process for preparing spirobenzofuranone compounds Download PDF

Info

Publication number
KR810001073B1
KR810001073B1 KR7803938A KR780003938A KR810001073B1 KR 810001073 B1 KR810001073 B1 KR 810001073B1 KR 7803938 A KR7803938 A KR 7803938A KR 780003938 A KR780003938 A KR 780003938A KR 810001073 B1 KR810001073 B1 KR 810001073B1
Authority
KR
South Korea
Prior art keywords
furan
benzo
cyclopropane
group
melting point
Prior art date
Application number
KR7803938A
Other languages
Korean (ko)
Inventor
히로사다 스기하라
마사즈미 와다나배
미쓰루 가와다
이스게 이마다
Original Assignee
다쓰오까 스에오
다께다 야꾸힝 고우교 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다쓰오까 스에오, 다께다 야꾸힝 고우교 가부시기가이샤 filed Critical 다쓰오까 스에오
Priority to KR7803938A priority Critical patent/KR810001073B1/en
Priority to KR1019810002429A priority patent/KR810001089B1/en
Application granted granted Critical
Publication of KR810001073B1 publication Critical patent/KR810001073B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones

Abstract

Title complds (I; A = alkyl, NO2, halo, amino, optionally substituted OH, acyl, sulfamoyl), useful as medicine, were prepd. by decarboxylic acid from II. Thus, 4',5'-dihydrospiro [benzo[b furan-2(3H),3'(2'H)-furan -2',3-dione 1.75 g, Nacl 552mg and dimethylsulfoxide 9ml were stirred for 2hr at 155oC under N2, poured in cold water, and the obtained precipitate was filtrated and recrystallized in EtOH-H2O(3:2) to give 1.21 g spiro[benzo[b furan-2(3H),1' -cyclopropan -3-one (m.p. 89-90.5oC).

Description

스프로벤조푸란온 화합물의 제조방법Process for the preparation of sprobenzofuranone compound

본원 발명은 의약 또는 의약제조용 중간체로서 유용한 새로운 골격구조를 갖는 스피로 화합물의 제조방법에 관한 것이다. 특히 본원 발명은 일반식The present invention relates to a method for preparing a spiro compound having a novel skeletal structure useful as a pharmaceutical or pharmaceutical preparation intermediate. In particular, the present invention is a general formula

Figure kpo00001
Figure kpo00001

로 나타내는 새로운 스피로 화합물의 제조방법에 관한 것이다(상기 식에서, 환 A는 벤젠환 또는 나프탈렌환을 나타내고, 그 벤젠환 또는 나프탈렌환은 치환되지 않거나, 저급알킬기 니트로기, 할로겐원자, 치환되어도 좋은 아미노기, 치환되어도 좋은 수산기, 아실기 그리고 술파모일기들중 적어도 한개 이상으로 치환되어도 좋다).(In the above formula, Ring A represents a benzene ring or a naphthalene ring, and the benzene ring or naphthalene ring is unsubstituted, a lower alkyl group nitro group, a halogen atom, an amino group which may be substituted, or a substitution). May be substituted with at least one of hydroxyl, acyl and sulfamoyl groups).

상기 일반식(Ⅰ)에 관하여, 환 A로 표시된 벤젠환이나 나프탈렌환은 치환되지 않아도 좋고 또는 위에 언급한 치환기들의 어떤 것들에 의하여 치환되어도 좋다. 지금부터 그러한 치환체들을 자세히 설명하고자 한다. 치환기로서의 저급알킬기로서는 탄소원자수 1-6개의 알킬기(예, 메틸에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, 2차부틸, 3차부틸, n-펜틸, 이소펜틸, n-헥실, 2-메틸펜틸, 2-에틸부틸 등)이 바람직하고 할로겐원소로서는 염소, 브롬, 플루오로, 요오드를 들 수 있다. 치환되어 있어도 좋은 아미노기로서 예를 들자면, 아미노기, 모노-또는 디-알킬아미노기, 아실아미노기, 술포닐아미노기, 시클로아미노기 등을 들 수 있다. 그러한 모노-또는 디-알킬아미노기는 탄소원자수 1-4개 정도의 알킬기로서 모노-또는 디-치환된 아미노기, 즉 메틸아미노, 에틸아미노, n-프로필아미노-이소프로필아미노, n-부틸아미노, 디메틸아미노, 디에틸아미노, 디-n-프로필아미노, 메틸에틸아미노기 등을 들 수 있다. 아실아미노기 예로서 탄소원자수 2-4개 정도의 알카노일아미노기(예, 아세틸아미노, 프로피오닐아미노, n-부티릴아미노, 이소부틸릴아미노기 등)를 들 수 있다. 술포닐 아미노기는 예를 들어 탄소수 1-4개 정도의 알칸술포닐아미노기(예, 메탄술포닐아미노, 에탄술포닐아미노기 등)를 들 수 있다. 시클로아미노기로서는 또는 0를 함유하여도 좋은 5-또는 6-환의 시클로아미노기, 예를 들면 피롤리디닐, 피페리디노, 피페라지닐, 모르포리노기 등을 들 수 있고, 피페라 지닐기는 더욱 그것의 4번 위치의 N원자가 탄소수 1-4개의 알킬기(예, 메틸, 에틸기), 페닐-C1-4알킬기(예, 벤질기) 또는 탄소수 2-4개의 알카노일기(예, 아세틸, 프로피오닐기)등에 의하여 치환되어도 좋다.Regarding the general formula (I), the benzene ring or the naphthalene ring represented by the ring A may not be substituted or may be substituted by any of the above-mentioned substituents. We will now describe such substituents in detail. Lower alkyl groups as substituents include alkyl groups having 1-6 carbon atoms (e.g., methylethyl, n-propyl, isopropyl, n-butyl, isobutyl, secondary butyl, tertiary butyl, n-pentyl, isopentyl, n-hexyl , 2-methylpentyl, 2-ethylbutyl, etc.), and examples of the halogen element include chlorine, bromine, fluoro and iodine. As an amino group which may be substituted, an amino group, a mono- or di-alkylamino group, an acylamino group, a sulfonylamino group, a cycloamino group, etc. are mentioned. Such mono- or di-alkylamino groups are alkyl groups having 1 to 4 carbon atoms and are mono- or di-substituted amino groups, ie methylamino, ethylamino, n-propylamino-isopropylamino, n-butylamino, dimethyl Amino, diethylamino, di-n-propylamino, methylethylamino group, etc. are mentioned. Examples of the acylamino group include alkanoylamino groups having about 2-4 carbon atoms (eg, acetylamino, propionylamino, n-butyrylamino, isobutylylamino group, etc.). The sulfonyl amino group includes, for example, an alkanesulfonylamino group (eg, methanesulfonylamino, ethanesulfonylamino group, etc.) having about 1 to 4 carbon atoms. As a cycloamino group or 5- or 6-cyclic cycloamino group which may contain 0, for example, a pyrrolidinyl, a piperidino, a piperazinyl, a morpholino group, etc. are mentioned, A piperazinyl group is further its N atom at position 4 is an alkyl group having 1 to 4 carbon atoms (e.g., methyl or ethyl group), a phenyl-C 1-4 alkyl group (e.g., benzyl group) or an alkanoyl group having 2 to 4 carbon atoms (e.g., acetyl, propionyl group It may be substituted by).

치환되어도 좋은 수산기의 예로는 히드록실기, 알콕시기, 아르알킬옥시기, 또는 아실옥시기 등이 있다. 특히 알콕시기는 탄소원자 1-3개의(예, 메톡시, 에톡시, n-프로폭시, 이소프로폭시, n-부톡시, 이소부톡시, 2차부톡시, 3차부톡시기)것이 바람직하며, 그 알콕시기는 예를 들어 모노-또는 디-C1-4알킬아미노기등(예, 메틸아미노, 에틸아미노, 디메틸아미노, 디에틸아미노)에 의해서 더욱 치환될 수 있다. 아르알킬옥시기는 예를 들면 페닐-C1-4알킬옥시기(예, 벤질옥시, 페넬틸옥시)이다. 아실옥시기는 특히 탄소원자수 2-6개 정도를 갖는 예를 들면 알카노일옥시기(예, 아세틸옥시, 프로피오닐옥시, n-부티릴옥시, 이소부티릴옥시기)이거나 또는 벤조일옥시기이다. 아실기는 예를 들어 탄소원자수 2-6개 정도의 알카노일기(예, 아세틸, 프로피오닐, n-부틸릴, 이소부티릴기)나 또는 벤조일기이다. 위에 언급된 환 A로서의 벤젠환이나 나프탈렌화의 이러한 치환체들은 그 환의 치환될 수 있는 임의의 위치에서 동일하거나 또는 다르게 1개에서 4개까지 치환되어도 좋다. 벤젠환은 그것의 5- 또는 6-위치(5-위치가 더욱 바람직하다)에, 치환되어도 좋은 아미노기(특히 모노-또는 디-C1-4알킬아미노기)에 의해서나 또는 아실기(특히, C2-4알카노일기)에 의해서 치환되는 것이 더 바람직하다. 본원 발명의 스피로화합물(Ⅰ)은 예를 들어서 다음의 일반식(Ⅱ)를 갖는 화합물을 탈탄산(脫炭酸)반응시킴으로써 제조된다.Examples of the hydroxyl group which may be substituted include a hydroxyl group, an alkoxy group, an aralkyloxy group, an acyloxy group and the like. In particular, the alkoxy group preferably has 1-3 carbon atoms (e.g., methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, secondary butoxy, tertiary butoxy group), and the alkoxy group The group may be further substituted, for example, with mono- or di-C 1-4 alkylamino groups and the like (eg methylamino, ethylamino, dimethylamino, diethylamino). Aralkyloxy groups are, for example, phenyl-C 1-4 alkyloxy groups (eg benzyloxy, phenethylyloxy). The acyloxy group is, for example, an alkanoyloxy group (eg, acetyloxy, propionyloxy, n-butyryloxy, isobutyryloxy group) having about 2-6 carbon atoms or a benzoyloxy group. The acyl group is, for example, an alkanoyl group having 2 to 6 carbon atoms (eg, an acetyl, propionyl, n-butylyl, isobutyryl group) or a benzoyl group. These substituents of the benzene ring or naphthalene as ring A mentioned above may be substituted from one to four identical or different at any position where the ring may be substituted. The benzene ring may be substituted at its 5- or 6-position (more preferably 5-position) by an amino group (particularly mono- or di-C 1-4 alkylamino group) which may be substituted or an acyl group (particularly C 2 More preferably a -4 alkanoyl group). The spiro compound (I) of this invention is manufactured by decarbonation-reacting the compound which has the following general formula (II), for example.

Figure kpo00002
Figure kpo00002

(상기 식에서 환 A는 앞에서 정의된 것과 같다)(Wherein A is as defined above)

이 반응은 일반적으로 탈탄산반응을 촉진시키는 촉매의 존재하에서 수행된다. 이러한 목적에 있어서의 좋은 촉매중에는 금속할로겐화물(예, 염화나트륨, 브롬화나트륨, 요오드화나트륨, 브롬화칼륨, 염화칼륨, 요오드화칼륨등)과 제4급 암모늄염(예, 테트라메틸암모늄 브로마이드등)이 있다. 반응온도에 있어서, 반응속도를 조절하는 것을 원한다면 그 반응은 더 높거나 더 낮은 온도에서 행해지지만 일반적으로 대략 100℃에서 200℃ 사이 특히 대략 140℃에서 160℃의 반응온도를 갖는다. 비활성기체(예를 들면 질소나 아르곤)로 반응용기를 깨끗이하는 것은 부반응을 억제하고 수득량을 증가시키는데 때때로 유효하다. 이 반응은 관례적으로 적당한 용매안에서 수행된다. 반응을 방해하지 않는 어떤 용매를 사용할 때 반응온도보다 높은 끓은점을 갖는 용매(예, 디메틸술폭시드, N,N'-디메틸포름아미드, 헥사메틸포스포아미드)를 사용하는 것이 대체로 유리하다. 본원 발명의 스피로화합물(Ⅰ) 사이에서 환 A에 하나나 또는 여러개의 치환체들을 갖는 화합물은 환 A가 치환되지 않은 화합물(Ⅰ) 또는 환 A에 적어도 1개이상의 수소원자를 갖는 화합물(Ⅰ)을, 목적으로 하는 치환기의 종류에 따라 자체공지의 알킬화반응, 니트로화반응, 할로겐화반응, 아실화반응 따위를 시킴으로서 제조된다.This reaction is generally carried out in the presence of a catalyst which catalyzes the decarbonation reaction. Good catalysts for this purpose include metal halides (eg sodium chloride, sodium bromide, sodium iodide, potassium bromide, potassium chloride, potassium iodide, etc.) and quaternary ammonium salts (eg tetramethylammonium bromide, etc.). At the reaction temperature, if desired to control the reaction rate, the reaction is carried out at a higher or lower temperature but generally has a reaction temperature between about 100 ° C. and 200 ° C., in particular between about 140 ° C. and 160 ° C. Cleaning the reaction vessel with an inert gas (eg nitrogen or argon) is sometimes effective to suppress side reactions and increase yield. This reaction is customarily carried out in a suitable solvent. When using any solvent that does not interfere with the reaction, it is generally advantageous to use a solvent having a boiling point higher than the reaction temperature (eg dimethyl sulfoxide, N, N'-dimethylformamide, hexamethylphosphoamide). Among the spiro compounds (I) of the present invention, a compound having one or more substituents in ring A includes a compound (I) in which ring A is not substituted or a compound (I) having at least one hydrogen atom in ring A. It is prepared by subjecting the known alkylation reaction, nitration reaction, halogenation reaction, acylation reaction according to the kind of substituent to be used.

또한 A의 치환기(들)가 아미노기(들)인 화합물(Ⅰ)은 아미노기(들)를 도입하려고하는 위치(들)에 수소원자(들)를 갖고 있는 화합물(Ⅰ)을 니트로화 시킨 후 촉매환원 반응 같은 환원반응을 시킴으로서 제조된다. 더욱 자체공지의 반응에 의하여 화합물(Ⅰ)의 환 A의 치환기(들)를 다른 치환기(들)로 변화시킬 수도 있다. 이를테면 환 A의 치환기(들)가 모노 또는 디-알킬아미노기(들)인 화합물(Ⅰ)은 치환기(들)가 아미노기(들)인 화합물(Ⅰ)을 환원성 알킬화반응 즉, 카르보닐 화합물(예, 포르말린 아세트알데히드, 아세톤)의 존재하에서 소듐시아노보로하이드라이드 따위의 금속수소화물로 환원시키거나, 촉매접촉 환원반응시키거나, 할로겐화알킬과 반응시켜 모노 또는 디알킬화반응을 시킴으로서 제조되어질 수 있다. 또한 모노 또는 디알킬아미노기(들)를 갖는 화합물(Ⅰ)은 치환기(들)가 니트로기(들)인 화합물(Ⅰ)을 위에 언급한 카르보닐화합물의 존재하에서 산화백금이나 라니-니켈 따위의 촉매를 써서 촉매접촉 환원반응을 시켜서 제조될 수 있다. 모노-또는 디-알킬아미노기를 갖는 화합물(Ⅰ)의 위에 설명한 제조는 예를 들어 다음의 반응도식에서 도해로써 설명될 수 있다.In addition, compound (I) in which the substituent (s) of A is an amino group (s) is catalytically reduced after nitrating compound (I) having hydrogen atom (s) at the position (s) to which amino group (s) are introduced. It is prepared by carrying out a reduction reaction such as a reaction. Furthermore, the substituent (s) of ring A of compound (I) may be changed to other substituent (s) by a known reaction. For example, compound (I) in which the substituent (s) of ring A is mono or di-alkylamino group (s) can react with compound (I) in which the substituent (s) are amino group (s), i.e., a carbonyl compound (e.g., It can be prepared by reducing with a metal hydride such as sodium cyanoborohydride in the presence of formalin acetaldehyde, acetone), by catalytic catalytic reduction, or by reacting with a halogenated alkyl to give mono or dialkylation. Compounds (I) having mono or dialkylamino group (s) can also be catalyzed by platinum or Raney-nickel in the presence of carbonyl compounds mentioned above for compounds (I) wherein the substituent (s) are nitro group (s). It can be prepared by catalytic catalytic reduction using. The preparation described above of compound (I) having a mono- or di-alkylamino group can be explained by way of example in the following scheme.

Figure kpo00003
Figure kpo00003

(여기에서 n은 1이나 2이고 R1은 앞에서 정의된 것과 같은 모노-또는 디-알킬아미노기이다).Wherein n is 1 or 2 and R 1 is a mono- or di-alkylamino group as defined above.

앞에서와 같은 방법으로 제조된 목적화합물(Ⅰ)은 보통의 분리정제수단(예, 종류, 재결정, 관크로마로그래피등)에 의하여 반응혼합물로부터 분리되며 정제될 수 있다. 또 화합물(Ⅰ)은 환 A의 치환체의 종류에 따라서 약제적으로 적합한 염으로 분리되어도 좋다. 예를 들면 치환체가 아미노기(예, 아미노기, 모노 또는 디알킬아미노기, 시클로아미노기)인 경우에 화합물(Ⅰ)은 산부가염(예, 염산염 또는 브롬화수소산염 따위의 광산(鑛酸)염이나 구연산염, 옥살산염 따위의 유기산)이며 치환체가 수산기(hydroxyl)인 경우에는 알칼리금속염(예, 나트륨염, 칼륨염 등)으로서 분리될 수 있다.The target compound (I) prepared in the same manner as described above can be separated and purified from the reaction mixture by ordinary separation and purification means (e.g., type, recrystallization, tube chromatography, etc.). Moreover, compound (I) may be isolate | separated into the pharmaceutically suitable salt according to the kind of substituent of ring A. For example, when the substituent is an amino group (e.g., an amino group, a mono or dialkylamino group, a cycloamino group), compound (I) is an acid addition salt (e.g. hydrochloride or hydrobromide, such as mineral salts, citrate, oxalic acid) Organic acids, such as salts), and the substituent may be separated as an alkali metal salt (eg, sodium salt, potassium salt, etc.).

본원 발명에 따른 스피로화합물(Ⅰ)은 새로운 골격구조를 갖는 화합물이며 이를테면 포유동물(예, 사람, 쥐, 생쥐, 모르모트, 개, 돼지)에 대하여 위액분리 억제작용, 소염작용, 진통작용등을 나타내며 예를 들어 십이지장궤양, 급만성위염, 요통, 관절염따위의 질병에 대하여 항궤양제, 소염제, 진통제로서 유용한 것이다. 그러한 의약으로서 사용되는 경우, 상기 화합물(Ⅰ)을 그대로 또는 자체공지의 운반제나 희석제와 함께 정제, 가루제, 캡슈울제, 주사제, 죄약등의 편리한 제형으로써 경구적 또는 비경구적으로 안전하게 투여할 수가 있다. 투여량은 투여대상, 중상, 투여루트등에 따라 다르나 보통 위, 십이지장궤양이나 급만성위염에 대한 치료제로서는 경구투여할 경우 화합물(Ⅰ)을 1회량 약 1-20㎎./kg체중 정도로 1일 약 1-3회 정도 투여하는 것이 좋다. 본원 발명 방법에 사용되는 원료화합물(Ⅱ)은 이를테면 아래의 합성방법 또는 이것에 준하는 방법에 의하여 제조될 수 있다.Spiro compound (I) according to the present invention is a compound having a new skeletal structure, for example, gastric juice separation inhibitory action, anti-inflammatory action, analgesic action and the like for mammals (eg, humans, mice, mice, morphotes, dogs, pigs). For example, it is useful as an anti-ulcer agent, anti-inflammatory agent, analgesic agent for diseases such as duodenal ulcer, acute gastritis, low back pain and arthritis. When used as such a medicament, the compound (I) can be safely administered orally or parenterally as it is or in a convenient formulation such as tablets, powders, capsules, injections, drugs, etc. together with a known carrier or diluent. . The dosage varies depending on the subject to be administered, the serious injury, and the route of administration, but usually, as a therapeutic agent for stomach, duodenal ulcer or acute gastritis, oral administration of Compound (I) is about 1-20 mg./kg body weight daily. It is recommended to administer 1-3 times. The raw material compound (II) used in the method of the present invention can be produced by, for example, the following synthesis method or a method similar thereto.

Figure kpo00004
Figure kpo00004

1) 가수분해, 락톤화1) hydrolysis, lactonation

2) (CH3CO)2O. (C2H5)3N2) (CH 3 CO) 2 O. (C 2 H 5 ) 3 N

(환 A는 앞에서 정의했던 것과 같다).(A has the same definition as before).

이하에서 본원 발명을 약물학적 시험예, 참고예, 실시예 등에 따라 이것을 더욱 구체적으로 설명하거니와 본원 발명의 범위가 이것들에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail according to pharmacological test examples, reference examples, examples and the like, but the scope of the present invention is not limited thereto.

약물학적 시험에Pharmacological test

본원 발명 화합물(Ⅰ)의 약리활성은 쥐의 위액분비억제시험에서 검정한 결과 다음과 같이 나타났다.The pharmacological activity of the compound (I) of the present invention was assayed in the gastric secretion inhibition test of rats as follows.

쉐이(shay)저 "위장병학" 5, 43(1945)의 방법에 따라 위액분비억제작용을 쥐의 유문결계법에 의하여 측정하였다.Gastric secretion inhibition was measured according to the method of Shay's "Gastrointestinal Disease" 5, 43 (1945).

5마리의 숫놈 스프라기-다울리(Sprague-Dawley)쥐, (각 체중 110-130)를 대조군 및 시험군에 대하여 사용했다. 시험전의 18시간동안에는 쥐에 물이외의 먹이를 주지 않았다. 유문(幽問)을 에테르 마취하에 잡아매어 각 시험화합물 용량 50㎎/kg을 결계시에 십이지장내에 투여하였다. 결계 3시간후에 쥐를 죽여 위액분비물을 모아 10분간 3500r.p.m으로 원심분리하여 위액양을 측정하였다. 그 결과를 아래의 표에 나타냈다.Five male Sprague-Dawley rats (each body weight 110-130) were used for the control and test groups. During the 18 hours before the test, rats were not fed except water. The pylorus was tied under ether anesthesia, and 50 mg / kg of each test compound dose was administered in the duodenum at the time of entrainment. After 3 hours of binding, rats were killed, gastric secretions were collected, and centrifuged at 3500 r.p.m for 10 minutes. The results are shown in the table below.

더욱 이들 화합물을 ICR계 쥐 5마리에다 500㎎/kg을 경구투여 하였다. 7일동안에 어떠한 무리의 쥐도 죽지 않았다.Furthermore, these compounds were orally administered with 500 mg / kg of 5 ICR mice. No flock of mice died in seven days.

[표][table]

쥐의 위액분비억제 작용Gastric Secretion Inhibition in Rats

Figure kpo00005
Figure kpo00005

[참고예 1]Reference Example 1

살리실산메틸에스테르 15.2g, 수산화나트륨 12g, N,N-디메틸포름아미드 150㎖의 혼합물에 얼음 냉각하에서 α-브로모-r-부티로락토 25g을 가한 다음 실온에서 28시간동안 저어준다. 반응액에 묽은 염산을 가하여 산성으로 만들고 초산에틸로써 추출한다. 추출액을 물로 씻어내고 건조시킨 후 감압하에서 농축시킨다. 잔류물을 30㎖의 메탄올에 용해시키고 20%의 수산화나트륨 수용액 150㎖를 떨어뜨려 가하고 55℃에서 30분간 저어준다. 반응 혼합물에 진한 염산 60㎖를 가하여 산성으로 만들고 생긴 침전물(살리실산)을 여과하여 제거하고 여과액을 초산에틸로써 추출시킨다. 그 추출액을 물로씻고 건조시킨 후 감압하에서 농축시킨다. 잔류물을 오산화인으로 24시간동안 진공건조시킨 다음 초산에틸-n-핵산(2 : 1)로부터 재결정하면 α-[(2-카르복시페닐)옥시]-r-부티로락톤의 무색침상결정 8.0g을 얻게 된다. 융점 113-115℃(핫-플레이트법(Hot-Plate method)에 의하여 측정되며 이하의 예들에서도 같은 방법으로 융점을 결정한다)To a mixture of 15.2 g of methyl salicylate, 12 g of sodium hydroxide and 150 ml of N, N-dimethylformamide was added 25 g of α-bromo-r-butyrolacto under ice cooling, followed by stirring at room temperature for 28 hours. Dilute hydrochloric acid is added to the reaction mixture to make it acidic and extracted with ethyl acetate. The extract is washed with water, dried and concentrated under reduced pressure. The residue is dissolved in 30 ml of methanol, added with 150 ml of 20% aqueous sodium hydroxide solution and stirred at 55 ° C. for 30 minutes. 60 ml of concentrated hydrochloric acid is added to the reaction mixture to make it acidic, and the resulting precipitate (salicylic acid) is filtered off and the filtrate is extracted with ethyl acetate. The extract is washed with water, dried and concentrated under reduced pressure. The residue was vacuum dried with phosphorus pentoxide for 24 hours and recrystallized from ethyl acetate-n-nucleic acid (2: 1) to give 8.0 g of colorless acicular crystal of α-[(2-carboxyphenyl) oxy] -r-butyrolactone. You get Melting point 113-115 ° C. (measured by Hot-Plate method and melting point is determined in the following examples in the same way)

원소분석치, C11H10O5로서Elemental Analysis Value, as C 11 H 10 O 5

계산치 : C, 59.46; H, 4.54Calculated: C, 59.46; H, 4.54

실측치 : C, 59.21; H, 4.51Found: C, 59.21; H, 4.51

[참고예 2]Reference Example 2

참고예 1과 같은 방법으로 5-클로로살리실산메틸에스테르 18.7g을 사용하여 α-[(2-카르복시-4-클로로페닐)옥시]-r-부티로락톤의 무색침상경정 9.3g을 얻는다. 용점 159-169.5℃18.7 g of 5-chlorosalicylic acid methyl ester was obtained in the same manner as in Reference Example 1 to obtain 9.3 g of a colorless needle crystal of α-[(2-carboxy-4-chlorophenyl) oxy] -r-butyrolactone. Melting point 159-169.5 ℃

원소분석치, C11H9ClO5로서Elemental Analysis Value, as C 11 H 9 ClO 5

계산치 : C, 51.48; H, 3.53; Cl, 13.82Calculated: C, 51.48; H, 3.53; Cl, 13.82

실측치 : C, 51.22; H, 3.50; Cl, 13.70Found: C, 51.22; H, 3.50; Cl, 13.70

[참고예 3]Reference Example 3

3-메틸살리실산 메틸에스테르 16.6g의 디메틸포름아미드 200㎖ 용액에 수소화나트륨(50% Bayol 85 현탁액) 5.3g을 가하고 이어서 얼음냉각 하에서 α-브로모-r-부티로락톤 18.2g의 디메틸포름아미드 10㎖ 용액을 적하한다. 실온에서 10시간 교반하여 섞은 다음 반응혼합물에 소량의 물을 더 넣고 용매를 감압하여 증류시켜 제거한다.To a 200 ml solution of 16.6 g of 3-methylsalicylic acid methyl ester of dimethylformamide, 5.3 g of sodium hydride (50% Bayol 85 suspension) was added, followed by 18.2 g of dimethylformamide a-bromo-r-butyrolactone under ice cooling. ML solution is added dropwise. The mixture is stirred at room temperature for 10 hours, and then a small amount of water is added to the reaction mixture, and the solvent is distilled off under reduced pressure.

그 잔류물에 20% 수산화나트륨 수용액 60㎖를 가하고 50-60℃에서 1시간동안 교반하여 섞는다. 반응혼합물에 진한염산 40㎖를 가하여 산성으로 만들고 석출되는 결정을 여과하여 얻어, 반응하지 않은 3-메틸살리실산을 회수한다. 여과액을 초산에틸로서 추출하고 물로 씻고 건조시켜 용매를 감압하에서 제거하고 잔류물을 오산화인으로 50℃에서 12시간동안 건조시킨 다음, 초산에틸-헥산으로부터 재결정하여 α-[(2-카르복시-6-메틸페닐)옥시]-r-부티로락톤의 무색 침상결정 12g을 얻는다. 융점은 129-131℃60 ml of 20% aqueous sodium hydroxide solution was added to the residue, followed by stirring at 50-60 ° C. for 1 hour. 40 ml of concentrated hydrochloric acid is added to the reaction mixture to make it acidic, and the precipitated crystals are filtered to recover unreacted 3-methylsalicylic acid. The filtrate was extracted with ethyl acetate, washed with water and dried to remove the solvent under reduced pressure, and the residue was dried over 50 hours at 50 ° C. with phosphorus pentoxide, and then recrystallized from ethyl acetate-hexane to give α-[(2-carboxy-6 12 g of colorless acicular crystals of -methylphenyl) oxy] -r-butyrolactone are obtained. Melting Point is 129-131 ℃

원소분석치, C12H12O5로서Elemental Analysis Value, as C 12 H 12 O 5

계산치 : C, 61.01; H, 5.12Calculated: C, 61.01; H, 5.12

실측치 : C, 61.00; H, 5.12Found: C, 61.00; H, 5.12

[참고예 4]Reference Example 4

3,5-디클로살리실산메틸에스테르 22g을 참고예 3과 같이 반응시켜 α-[(2-카르복시-4,6-디클로로페닐)옥시]-r-부티로락톤의 무색결정 14g을 얻는다. 융점은 129-131℃22 g of 3,5-diclosalicylic acid methyl ester was reacted as in Reference Example 3 to obtain 14 g of colorless crystals of α-[(2-carboxy-4,6-dichlorophenyl) oxy] -r-butyrolactone. Melting Point is 129-131 ℃

원소분석치, C118HCl2O5로서Elemental Analysis Value, as C 118 HCl 2 O 5

계산치 : C, 45.38; H, 2.77Calculated: C, 45.38; H, 2.77

실측치 : C, 45.43; H, 2.66Found: C, 45.43; H, 2.66

[참고예 5]Reference Example 5

5-벤징옥시살리실산메틸에스테르 32g, 무수탄산칼륨 17g, 및 아세톤 500㎖의 혼합물에 얼음 냉각하에서 α-브로모-r-부티로락톤 30.7g을 가하여 15시간 동안 가열 환류시킨다. 냉각후 아세톤을 증류하여 제거하고 잔류물에 10%메탄올성 수산화나트륨을 가하여 가수분해시킨다. 반응혼합물을 염산 산성으로하여 초산에틸로서 추출시킨다. 추출액을 물로 씻고 무수황산나트륨으로 건조시킨 후 용매를 증류시켜 제거한다. 잔류물을 디옥산(300㎖)-벤젠(200㎖)에 녹이고 그 용액을 P-톨루엔술폰산(30g)의 존재하에서, 생성되는 물을 증류시켜 제거하면서, 가열 환류시킨다. 용매를 증류 제거하고 잔류물은 물로 희석시키고 초산에틸로 추출시킨다. 추출물을 물로 씻고 건조, 농축시켜서 용매를 제거하고, 잔류물을 초산에틸로부터 재결정시켜서 α-[(2-카르복시-4-벤질옥시페닐)옥시]-r-부티로락톤의 무색침상결정 21.5g을 얻는다. 융점은 120-122℃To a mixture of 32 g of 5-benzoxysalicylate methyl ester, 17 g of anhydrous potassium carbonate, and 500 ml of acetone was added 30.7 g of α-bromo-r-butyrolactone under ice cooling and heated to reflux for 15 hours. After cooling, acetone is distilled off and hydrolyzed by adding 10% methanolic sodium hydroxide to the residue. The reaction mixture is made acidic with hydrochloric acid and extracted as ethyl acetate. The extract is washed with water, dried over anhydrous sodium sulfate and the solvent is distilled off. The residue is taken up in dioxane (300 mL) -benzene (200 mL) and the solution is heated to reflux with distillation of the resulting water in the presence of P-toluenesulfonic acid (30 g). The solvent is distilled off and the residue is diluted with water and extracted with ethyl acetate. The extract was washed with water, dried and concentrated to remove the solvent, and the residue was recrystallized from ethyl acetate to give 21.5 g of colorless acicular crystal of α-[(2-carboxy-4-benzyloxyphenyl) oxy] -r-butyrolactone. Get Melting Point is 120-122 ℃

원소분석치, C18H16O6로서Elemental Analysis Value, as C 18 H 16 O 6

계산치 : C, 65.85; H, 4.91Calculated: C, 65.85; H, 4.91

실측치 : C, 65.86; H, 4.96Found: C, 65.86; H, 4.96

[참고예 6-12]Reference Example 6-12

참고예 5와 같은 방법으로 얻어지는 화합물을 아래에 나타낸다.The compound obtained by the method similar to the reference example 5 is shown below.

Figure kpo00006
Figure kpo00006

[참고예 13]Reference Example 13

4-아세틸아미노-5-클로로-2-히드록시안식향산메틸에스테르 51g과 무수탄산칼륨 36.8g을 N,N-디메틸포름아미드 350㎖에 현탁시켜 α-브로모-r-브티로락톤 55g에 가하여 60℃에서 12시간동안 교반하여 섞는다. 용매를 감압하에서 증발시키고 잔류물을 물로 희석시키고 초산에틸로 추출시킨다. 추출액을 물로씻고 건조, 농축시켜 용매를 제거한다. 잔류물을 클로로포름에 녹여 실리카 겔 관크로마토그래피에 붙힌다. 클로로포름으로서 용출시켜, 메탄올로부터 재결정된 담황색프리즘결정의 α-[(5-아세틸아미도-4-클로로-2-메톡시카르보닐페닐)옥시]-r-부티로락톤 32g을 얻는다. 융점은 118-119℃51 g of 4-acetylamino-5-chloro-2-hydroxybenzoic acid methyl ester and 36.8 g of anhydrous potassium carbonate were suspended in 350 ml of N, N-dimethylformamide and added to 55 g of α-bromo-r-butyrolactone and 60 Stir at 12 ° C. for 12 hours and mix. The solvent is evaporated under reduced pressure and the residue is diluted with water and extracted with ethyl acetate. The extract is washed with water, dried and concentrated to remove the solvent. The residue is taken up in chloroform and attached to silica gel column chromatography. Elution as chloroform gives 32 g of α-[(5-acetylamido-4-chloro-2-methoxycarbonylphenyl) oxy] -r-butyrolactone of the pale yellow prism crystal recrystallized from methanol. Melting Point is 118-119 ℃

원소분석치, C14H14O6NCl로서Elemental Analysis, C 14 H 14 O 6 NCl

계산치 : C, 51.31; H, 4.31; N, 4.27Calculated: C, 51.31; H, 4.31; N, 4.27

실측치 : C, 51.24; H, 4.26; N, 4.16Found: C, 51.24; H, 4. 26; N, 4.16

[참고예 14]Reference Example 14

4-아세틸아미노-2-히드록시안식향산 메틸에스테르 63g을 참고예 13과 같은 방법으로 반응시켜 그 생성물을 실리카겔 관크로마토그래피에 붙여 두화분(2畵分)으로 분화(分畵)한다. 화분 1에서 얻은 결정을 메탄올로부터 재결정시켜서 무색판상결정의 6-아세틸아미노-4', 5'-디히드로스피로[벤조[b]-푸란]-2', 3-디온 1.4g을 얻는다. 융점은 220-234℃63 g of 4-acetylamino-2-hydroxybenzoic acid methyl ester are reacted in the same manner as in Reference Example 13, and the product is attached to silica gel column chromatography to differentiate into two fractions. The crystals obtained in pollen 1 are recrystallized from methanol to obtain 1.4 g of 6-acetylamino-4 ', 5'-dihydrospiro [benzo [b] -furan] -2', and 3-dione as colorless plate crystals. Melting Point is 220-234 ℃

원소분석치, C13H11O5N로서Elemental Analysis Value, as C 13 H 11 O 5 N

계산치 : C, 59.77; H, 4.24; N, 5.36Calculated: C, 59.77; H, 4. 24; N, 5.36

실측치 : C, 59.71; H, 4.21; N, 5.28Found: C, 59.71; H, 4. 21; N, 5.28

화분 2로부터 담황색 유상(油狀)의 α-[(5-아세틸아미노-2-메톡시 카르보닐페닐)옥시]-r-부티로락톤 35g을 얻는다. 이 유상물은 또 다시 정제하는일 없이 다음의 공정에 붙일 수 있다.From pollen 2, 35 g of pale yellow oily α-[(5-acetylamino-2-methoxy carbonylphenyl) oxy] -r-butyrolactone is obtained. This oil can be added to the next step without refining.

핵자기공명스펙트럼(CDCl3) : 2.10(3H,s,NCOCH3), 2.65(2H,m,CH2), 3.83(3H,s,COOCH3), 4.45(2H,m,OCH2), 4.98(1H,t,OCHCO), 7.09(1H,d, 방향족환 H), 7.66(1H,s, 방향족환 H), 7.73(1H,d 방향족환 H).Nuclear Magnetic Resonance Spectrum (CDCl 3 ): 2.10 (3H, s, NCOCH 3 ), 2.65 (2H, m, CH 2 ), 3.83 (3H, s, COOCH 3 ), 4.45 (2H, m, OCH 2 ), 4.98 (1H, t, OCHCO), 7.09 (1H, d, aromatic ring H), 7.66 (1H, s, aromatic ring H), 7.73 (1H, d aromatic ring H).

[참고예 15]Reference Example 15

α-[(2-카르복시-6-메틸페닐)옥시]-r-부티로락톤 24.4g을 발연질산 120㎖에 40℃이하에서 가한다. 반응액을 얼음물에 붓고 석출하는 결정을 여과하여 취해서 물로 씻고 건조시킨 후 메탄올로 재결정시켜 담황색프리즘 결정의 α-[(2-카르복시-6-메틸-4-니트로페닐)옥시]-r-부티로락톤 20.3g을 얻는다. 융점은 210℃ (분해).24.4 g of α-[(2-carboxy-6-methylphenyl) oxy] -r-butyrolactone are added to 120 ml of fuming nitric acid at 40 캜 or lower. The reaction solution was poured into iced water, and the precipitated crystals were collected by filtration, washed with water, dried and recrystallized with methanol to give α-[(2-carboxy-6-methyl-4-nitrophenyl) oxy] -r-butyro as a pale yellow prism crystal. Obtain 20.3 g of lactone. Melting point 210 deg.

원소분석치, C12H11O7N로서Elemental Analysis Value, as C 12 H 11 O 7 N

계산치 : C, 51.25; H, 3.94; N, 4.98Calculated: C, 51.25; H, 3.94; N, 4.98

실측치 : C, 51.16; H, 3.93; N, 4.82Found: C, 51.16; H, 3.93; N, 4.82

[참고예 16]Reference Example 16

살리실산 메틸에스테르(3.04)와 α-브로모-r-부티로락톤을 참고예 1의 해당공정과 같은 방법으로 반응시켜 메탄올로부터 재결정하여 무색침상결정의 α-[(2-메톡시카르보닐페닐)옥시]-r-부티로락톤 3.3g을 얻는다. 융점은 62-87℃Reaction of methyl salicylic acid methyl ester (3.04) with α-bromo-r-butyrolactone in the same manner as in the corresponding step of Reference Example 1 was recrystallized from methanol to give α-[(2-methoxycarbonylphenyl) as a colorless needle. 3.3 g of oxy] -r-butyrolactone are obtained. Melting point is 62-87 ℃

원소분석치, C12H12O5로서Elemental Analysis Value, as C 12 H 12 O 5

계산치 : C, 61.01; H, 5.12Calculated: C, 61.01; H, 5.12

실측치 : C, 60.98; H, 4.99Found: C, 60.98; H, 4.99

[참고예 17]Reference Example 17

α-[(2-카르복시페닐)옥시]-r-부티로락톤 1.38g, 무수초산 15 및 트리에틸아민 3㎖의 혼합물을 질소기류안, 140℃에서 3.5시간 저어섞은 다음 감압하에서 용매를 증류시킨다. 잔류물을 실리카겔 32.5g과 사염화탄소-아세톤(10 : 1)을 써서 관크로마토그래피에 붙여 원하는 화분(畵分)을 분취하여 감압하에서 농축시켜 n-헥산-초산에틸(3 : 1)로부터 재결정시키면 4', 5'-디히드로스피로 [벤조[b]-푸란-2(3H), 3'(2'H)-푸란]-2',3-디온의 무색침상결정 633㎎을 얻게 된다. 융점은 111-111.5℃A mixture of 1.38 g of α-[(2-carboxyphenyl) oxy] -r-butyrolactone, 15 ml of acetic anhydride and 3 ml of triethylamine was stirred for 3.5 hours at 140 ° C. in a nitrogen stream, and the solvent was distilled off under reduced pressure. . The residue was added to tube chromatography using 32.5 g of silica gel and carbon tetrachloride-acetone (10: 1), and the desired pollen was collected, concentrated under reduced pressure, and recrystallized from n-hexane-ethyl acetate (3: 1). 633 mg of colorless needles of 5'-dihydrospiro [benzo [b] -furan-2 (3H) and 3 '(2'H) -furan] -2', 3-dione were obtained. Melting Point is 111-111.5 ℃

원소분석치, C11H8O4로서Elemental Analysis Value, as C 11 H 8 O 4

계산치 : C, 64.70; H, 3.95Calculated: C, 64.70; H, 3.95

실측치 : C, 64.74; H, 3.70Found: C, 64.74; H, 3.70

[참고예 18-29]Reference Example 18-29

참고예 17과 똑같은 방법으로 얻어지는 화합물을 아래에 나타낸다.The compound obtained by the method similar to the reference example 17 is shown below.

Figure kpo00007
Figure kpo00007

(표에서 ph는 페닐기를 나타낸다).(Ph in the table represents a phenyl group).

[참고예 30]Reference Example 30

α-[(5-아세틸아미노-4-클로로-2-메톡시카르보닐페닐)옥시]-r-부티로락톤 23g, 트리에틸아민 46㎖ 및 무수초산 230㎖의 혼합물을 120℃에서 5시간동안 가열한다. 용매를 감압하에서 증발시키고, 잔류물을 얼음물에 부어서 석출하는 결정을 여과하여 취해, 물로씻고 건조시킨 후 초상에 틸로부터 재결정하여 무색 주상(柱狀)결정인 6-디아세틸아미노-5-클로로-4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온 6.8g을 얻는다. 융점은 181-185℃A mixture of 23 g of α-[(5-acetylamino-4-chloro-2-methoxycarbonylphenyl) oxy] -r-butyrolactone, 46 ml of triethylamine and 230 ml of acetic anhydride was added at 120 ° C. for 5 hours. Heat. The solvent was evaporated under reduced pressure, and the residue was poured into iced water, and the precipitated crystals were collected by filtration, washed with water and dried and then recrystallized from til to give 6-diacetylamino-5-chloro- as a colorless columnar crystal. 6.8 g of 4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione is obtained. Melting Point is 181-185 ℃

원소분석치, C15H12O6NCl로서Elemental Analysis Value, as C 15 H 12 O 6 NCl

계산치 : C, 53.34; H, 3.58; N, 4.15Calculated: C, 53.34; H, 3.58; N, 4.15

실측치 : C, 53.08; H, 3.49; N, 4.12Found: C, 53.08; H, 3. 49; N, 4.12

[참고예 31]Reference Example 31

α-[(5-아세틸아미노-2-메톡시카르보닐페닐)옥시]-r-부티로락톤 39g을 참고예 30에서와 같은 방법으로 반응시켜 6-아세틸아미노-4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온 1.8g(융점은 220-234℃)과 6-디아세틸아미노-4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온 2.7g(융점은 178℃)을 얻는다.39 g of α-[(5-acetylamino-2-methoxycarbonylphenyl) oxy] -r-butyrolactone was reacted in the same manner as in Reference Example 30 to give 6-acetylamino-4 ', 5'-dihydro 1.8 g of pyro [benzo [b] furan-2 (3H), 3 '(2'H) -furan] -2', 3-dione (melting point: 220-234 ° C) and 6-diacetylamino-4 ', 2.7 g of 5'-dihydrospiro [benzo [b] furan-2 (3H), 3 '(2'H) -furan] -2', 3-dione (melting point: 178 ° C) is obtained.

원소분석치, C15H13O6N로서Elemental analysis value as C 15 H 13 O 6 N

계산치 : C, 59.40; H, 4.32; N, 4.62Calculated: C, 59.40; H, 4. 32; N, 4.62

실측치 : C, 59.49; H, 4.21; N, 4.34Found: C, 59.49; H, 4. 21; N, 4.34

[참고예 32]Reference Example 32

α-[(2-메톡시카르보닐페닐)옥시]-r-부티로락톤 1.1g을 참고예 17과 똑같이 처리하여, 그 생성물을 초산에틸-헥산으로부터 재결정시켜 4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온 330㎎의 무색침상 결정을 얻는다. 융점은 111-111.5℃1.1 g of α-[(2-methoxycarbonylphenyl) oxy] -r-butyrolactone was treated in the same manner as in Reference Example 17, and the product was recrystallized from ethyl acetate-hexane to give 4 ', 5'-dihydrospiro 330 mg of colorless needles of [benzo [b] furan-2 (3H), 3 '(2'H) -furan] -2', 3-dione are obtained. Melting Point is 111-111.5 ℃

[참고예 33]Reference Example 33

4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온0.408g의 진한 황산 3㎖용액의 질산 (d=1.42) 0.35㎖, 진한 황산 0.36㎖의 혼합액을 얼음냉각하에서 적하하여 2시간동안 저어준다. 반응혼합물을 얼음물에 붓고 석출하는 결정을 여과하여 취하고 물로씻고 건조시킨 후 초산에틸로 재결정하며 4',5'-디히드로-5-니트로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온의 무색침상 결정을 얻게 된다. 융점은 199-200℃0.48 g of 4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione nitric acid (d) = 1.42) A mixture of 0.35 ml and 0.36 ml of concentrated sulfuric acid is added dropwise under ice cooling and stirred for 2 hours. The reaction mixture was poured into iced water, and the precipitated crystals were filtered off, washed with water and dried, and then recrystallized with ethyl acetate. 4 ', 5'-dihydro-5-nitrospiro [benzo [b] furan-2 (3H), 3' A colorless acicular crystal of (2'H) -furan] -2 ', 3-dione is obtained. Melting Point is 199-200 ℃

원소분석치, C11H7NO6로서Elemental Analysis Value, as C 11 H 7 NO 6

계산치 : C, 53.02; H, 2.83; N, 5.62Calculated: C, 53.02; H, 2.83; N, 5.62

실측치 : C, 52.89; H, 2.65; N, 5.55Found: C, 52.89; H, 2. 65; N, 5.55

[참고예 34]Reference Example 34

4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온(3g)과 클로로술폰산의 혼합물을 실온에서 그리고 이어서 40℃에서 1.5시간동안 저어준다. 반응혼합물을 얼음물에 부어 백색결정을 얻고, 그 결정을 테트라히드로푸란용액에 용해시키고 암모니아수(2.2㎖)를 가하고 그 혼합액을 얼음냉각하에서 5분간 저어준다. 석출분말을 여과하여 버리고 여과액을 감압하에서 농축시켜 그 잔류물을 에탄올-물로부터 재결정시키면 5-술파모일-4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온의 무색침상 결정 2.8g을 얻게 된다. 융점은 202-215℃A mixture of 4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione (3 g) with chlorosulfonic acid and Then stir at 40 ° C. for 1.5 hours. The reaction mixture was poured into iced water to obtain white crystals. The crystals were dissolved in tetrahydrofuran solution, ammonia water (2.2 mL) was added, and the mixture was stirred for 5 minutes under ice cooling. The precipitated powder was filtered off and the filtrate was concentrated under reduced pressure, and the residue was recrystallized from ethanol-water to give 5-sulfamoyl-4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3. 2.8 g of colorless needles of '(2'H) -furan] -2', 3-dione are obtained. Melting Point is 202-215 ℃

원소분석치, C11H9O6NS로서Elemental Analysis Value, as C 11 H 9 O 6 N S

계산치 : C, 46.64; H, 3.20; N, 4.95Calculated: C, 46.64; H, 3. 20; N, 4.95

실측치 : C, 46.39; H, 3.14; N, 4.87Found: C, 46.39; H, 3.14; N, 4.87

[실시예 1]Example 1

4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온1.75g, 염화나트륨 552㎎ 및 디메틸술폭시드 9㎖의 혼합물을 질소기류안, 155℃에서 2시간동안 저어준다. 반응혼합물을 얼음물(약 150㎖)에 붓고 생기는 석출물을 여과하여 얻어서 물로씻고 에탄올-물(3 : 2)로부터 재결정하여, 스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온의 무색침상결정 1.21g을 얻는다. 융점은 89-90.5℃4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione1.75 g, sodium chloride 552 mg and dimethyl sulfoxide 9 ml The mixture was stirred at 155 ° C. for 2 hours in a stream of nitrogen. The reaction mixture was poured into iced water (about 150 mL), and the precipitate formed was collected by filtration, washed with water, recrystallized from ethanol-water (3: 2), and spiro [benzo [b] furan-2 (3H), 1'-cyclopropane]. Obtain 1.21 g of colorless acicular crystals of 3-one. Melting Point is 89-90.5 ℃

원소분석치, C10H8O2로서Elemental analysis value, as C 10 H 8 O 2

계산치 : C, 74.99; H, 5.03Calculated: C, 74.99; H, 5.03

실측치 : C, 74.71; H, 4.96Found: C, 74.71; H, 4.96

[실시예 2-15]Example 2-15

실시예 1과 같은 방법으로 제조되는 혼합물을 아래에 나타냈다.The mixture prepared in the same manner as in Example 1 is shown below.

Figure kpo00008
Figure kpo00008

(표중 ph는 페닐기를 Ac는 아세틸기를 나타낸다)(Ph in the table represents a phenyl group, Ac represents an acetyl group)

[실시예 16]Example 16

4',5'-디히드로스피로[나프로[2,3-b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온(1.2g)을 실시예 1과 같은 방법으로 반응시켜 반응혼합물을 메탄올로부터 재결정시키면 스피상[토나프[2,3-b]푸란-2(3H),1'-시클로프로판]-3-온의 무색침상결정 0.75g을 얻게된다.Example 4 ', 5'-dihydrospiro [napro [2,3-b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione (1.2 g) When the reaction mixture was recrystallized from methanol in the same manner as in 1, 0.75 g of colorless needles of spi [[naph [2,3-b] furan-2 (3H), 1'-cyclopropane] -3-one were obtained. Get

융점은 127-129℃Melting Point is 127-129 ℃

원소분석치, C14H10O2로서Elemental Analysis Value, as C 14 H 10 O 2

계산치 : C, 79.98; H, 4.79Calculated: C, 79.98; H, 4.79

실측치 : C, 79.89; H, 4.65Found: C, 79.89; H, 4.65

[실시예 17]Example 17

5-헥실-4',5'-디히드로스피로[벤조[b]푸란-2(3H),3'(2'H)-푸란]-2',3-디온을 실시예 1과 같이 카르복시 이탈반응시켜서 담황색 유상(油狀)의 5-헥실스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다.Carboxy leaving 5-hexyl-4 ', 5'-dihydrospiro [benzo [b] furan-2 (3H), 3' (2'H) -furan] -2 ', 3-dione as in Example 1 The reaction is carried out to obtain pale yellow oily 5-hexylspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one.

Figure kpo00009
; 1700(CO)
Figure kpo00009
; 1700 (CO)

NMR(CDCl3)δ; 087(3H,t,CH3), 1.36(8H,b,CH2) 1.59(4H,m, 시클로로프로판), 2.63(2H,t, 핵 CH2) 7.02(1H,d, 핵 H), 7.40(1H,d, 핵 H), 4.48 (1H,s, 핵 H)NMR (CDCl 3 ) δ; 087 (3H, t, CH 3 ), 1.36 (8H, b, CH 2 ) 1.59 (4H, m, cychloropropane), 2.63 (2H, t, nuclear CH 2 ) 7.02 (1H, d, nuclear H), 7.40 (1H, d, nuclear H), 4.48 (1H, s, nuclear H)

원소분석치, C16H20O2로서Elemental Analysis Value, as C 16 H 20 O 2

계산치 : C, 78.65; H, 8.25Calculated: C, 78.65; H, 8.25

실측치 : C, 78.37; H, 8.36Found: C, 78.37; H, 8.36

[실시예 18]Example 18

스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온-0.94g을 무수초산 30㎖에 용해시켜 60-70℃에서 질산동 5.6g을 가해 그 용액을 밤새도록 저어준다. 반응혼합물을 얼음물에 가하고 초산에틸로 추출한다. 추출액을 물로씻고 건조시킨 후 용매를 증류시켜 제거하고 잔유물을 실리카겔 관크로마토그래피에 붙여 2화분으로 분리한다.Spiro [benzo [b] furan-2 (3H) and 1'-cyclopropane] -3-one-0.94 g were dissolved in 30 ml of anhydrous acetic acid, and 5.6 g of copper nitrate was added at 60-70 ° C. to keep the solution overnight. Stir. The reaction mixture is added to ice water and extracted with ethyl acetate. The extract was washed with water, dried, the solvent was distilled off and the residue was separated on two gels, followed by silica gel column chromatography.

(1) 제1화분을 초산에틸-n-헥산으로 재결정시켜 무색주상 결정인 5-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다. 융점은 107-110℃(1) The first pot is recrystallized with ethyl acetate-n-hexane to give 5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as colorless columnar crystals. Melting point is 107-110 ℃

원소분석치, C10H7NO4로서Elemental Analysis Value, as C 10 H 7 NO 4

계산치 : C, 58.54; H, 3.44; N, 6.83Calculated: C, 58.54; H, 3. 44; N, 6.83

실측치 : C, 58.85; H, 3.50; N, 6.68Found: C, 58.85; H, 3.50; N, 6.68

(2) 제2화분을 초산에틸로부터 재결정하여 7-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-온의 무색침상 결정을 얻는다. 융점은 131-134℃(2) The second pot is recrystallized from ethyl acetate to obtain colorless needles of 7-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -one. Melting point is 131-134 ℃

원소분석치, C10H7NO4로서Elemental Analysis Value, as C 10 H 7 NO 4

계산치 : C, 58.54; H, 3.44; N, 6.83Calculated: C, 58.54; H, 3. 44; N, 6.83

실측치 : C, 58.42; H, 3.37; N, 6.65Found: C, 58.42; H, 3. 37; N, 6.65

[실시예 19]Example 19

스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(7.0g)을-50℃--60℃까지로 미리 냉각된 발연질산(70㎖)에 소량씩 가한다. 20분간 저어준 다음 반응액을 얼음물에 붓고 석출되는 결정을 여과해 얻어서 물로씻고 에탄올로부터 재결정하면 무색주상 결정인 5-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 7.3g을 얻게 된다. 융점은 107-110℃이 생성물은 실시예 18에서 얻은 결정과 일치한다. 재결정모액을 실리카겔관 크로마토그래피에 붙여 분리하고 메탄올로부터 재결정하여 담황색침상 결정인 5,7-디니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다. 융점은 158-161℃Spiro [benzo [b] furan-2 (3H) and 1'-cyclopropane] -3-one (7.0 g) are added in small portions to fumed nitric acid (70 ml) previously cooled down to -50 ° C to 60 ° C. do. After stirring for 20 minutes, the reaction solution was poured into iced water, the precipitated crystals were filtered off, washed with water and recrystallized from ethanol to give 5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] as colorless columnar crystals. 7.3 g of 3-one is obtained. The melting point is 107-110 ° C. The product is consistent with the crystals obtained in Example 18. The recrystallized mother liquor is subjected to silica gel column chromatography to separate and recrystallized from methanol to obtain 5,7-dinitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as pale yellow needle crystals. . Melting Point is 158-161 ℃

원소분석치, C10H6O6N2로서Elemental analysis value, as C 10 H 6 O 6 N 2

계산치 : C, 48.01; H, 2.42; N, 11.20Calculated: C, 48.01; H, 2. 42; N, 11.20

실측치 : C, 48.03; H, 2.33; N, 11.01Found: C, 48.03; H, 2. 33; N, 11.01

[실시예 20]Example 20

6-메톡시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 5.4g을 무수초산 25㎖와 빙초산 7㎖와의 혼합액에 용해시켜 반응온도를 10-15℃로 유지하면서 발연질산(d=1.52)3㎖를 적하한다. 30분간 젓고 얼음물에 부어서 결과의 석출물을 여과하여 취해서, 물을 씻고 에탄올로부터 재결정하면 담황색프리즘상 결정인 6-메톡시-5-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 4.5g을 얻게 된다. 융점은 160-163℃5.4 g of 6-methoxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one was dissolved in a mixed solution of 25 ml of anhydrous acetic acid and 7 ml of glacial acetic acid, and the reaction temperature was 10-15 ° C. 3 ml of fuming nitric acid (d = 1.52) was added dropwise while maintaining the solution temperature. Stir for 30 minutes, pour into iced water, filter out the resulting precipitate, wash the water and recrystallize from ethanol. 6-methoxy-5-nitrospiro [benzo [b] furan-2 (3H), 1 ' 4.5 g of cyclopropane] -3-one are obtained. Melting Point is 160-163 ℃

원소분석치, C11H9NO5로서Elemental Analysis Value, as C 11 H 9 NO 5

계산치 : C, 56.17; H, 3.86; N, 5.96Calculated: C, 56.17; H, 3.86; N, 5.96

실측치 : C, 56.44; H, 3.76; N, 5.80Found: C, 56.44; H, 3.76; N, 5.80

[실시예 21]Example 21

6-메톡시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 190㎎을 -50℃에서 발연질산(d=1.52)2㎖를 저어주면서 가한다. 10분후 반응액을 얼음물에 붓고 초산에틸로써 추출한다. 추출액을 중탄산나트륨 수용액과, 이어서 포화식염수로 씻어내고 무수황산나트륨으로 건조시킨다. 용매를 증발시켜서 얻은 결정을 메탄올로부터 재결정하면 담황색 판상결정인 6-메톡시-5,7-디니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-은 20㎎을 얻는다. 융점은 121-124℃190 mg of 6-methoxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one is added while stirring 2 ml of fuming nitric acid (d = 1.52) at -50 ° C. After 10 minutes, the reaction solution was poured into iced water and extracted with ethyl acetate. The extract is washed with an aqueous sodium bicarbonate solution, followed by saturated brine and dried over anhydrous sodium sulfate. The crystals obtained by evaporation of the solvent were recrystallized from methanol to give 6-methoxy-5,7-dinitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3- as a pale yellow plate crystal. Get mg. Melting point is 121-124 ℃

원소분석치, C18H8O7N2로서Elemental Analysis Value, as C 18 H 8 O 7 N 2

계산치 : C, 47.15; H, 2.88; N, 10.00Calculated: C, 47.15; H, 2.88; N, 10.00

실측치 : C, 46.86; H, 2.79; N, 9.83Found: C, 46.86; H, 2.79; N, 9.83

[실시예 22]Example 22

5-니트로스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(7.2g)의 에탄올용액을 이산화백금의 존재하 수소기류안에서 저어준다. 수소 흡수가 끝난 다음 촉매를 여과하여, 그 여과액을 감압하에서 증류하고 잔류물에 소량의 염산-디에틸 에스테르를 가하여 에탄올로부터 재결정하여 연한갈색의 침상결정인 5-아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다.An ethanol solution of 5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (7.2 g) is stirred in a hydrogen stream in the presence of platinum dioxide. After hydrogen absorption, the catalyst was filtered off, the filtrate was distilled under reduced pressure, and a small amount of hydrochloric acid-diethyl ester was added to the residue to recrystallize from ethanol to give 5-aminospiro [benzo [b] furan, a light brown needle. -2 (3H), 1'-cyclopropane] -3-one.

융점은 139-142℃Melting Point is 139-142 ℃

원소분석치, C10H19O2NHCl로서Elemental Analysis, C 10 H 19 O 2 NHCl

계산치 : C, 56.75; H, 4.76; N, 6.62Calculated: C, 56.75; H, 4.76; N, 6.62

실측치 : C, 56.67; H, 4.83; N, 6.67Found: C, 56.67; H, 4.83; N, 6.67

[실시예 23]Example 23

7-니트로스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온을 실시예 22와 같은 방법으로 반응시켜 에탄올로부터 재결정하여 담갈색 결정인 7-아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다. 융점은 135.8℃7-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one was reacted in the same manner as in Example 22 and recrystallized from ethanol to give 7-aminospiro [benzo [ b] furan-2 (3H), 1'-cyclopropane] -3-one. Melting point is 135.8 ℃

원소분석치, C10H19O2N으로서Elemental Analysis Value, As C 10 H 19 O 2 N

계산치 : C, 68.56; H, 5.18; N, 8.00Calculated: C, 68.56; H, 5. 18; N, 8.00

실측치 : C, 68.42; H, 5.49; N, 7.74Found: C, 68.42; H, 5.49; N, 7.74

[실시예 24]Example 24

6-메톡시-5-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 1.0g을 실시예 22와 같은 방법으로 반응시켜 그 반응생성물을 에탄올로부터 재결정하여 담갈색 결정인 5-아미노-6-메톡시스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 415㎎을 얻는다. 융점은 175-177℃1.0 g of 6-methoxy-5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one was reacted in the same manner as in Example 22, and the reaction product was recrystallized from ethanol. 415 mg of 5-amino-6-methoxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as light brown crystals was obtained. Melting Point is 175-177 ℃

원소분석치, C11H11NO3로서Elemental Analysis Value, as C 11 H 11 NO 3

계산치 : C, 64.38; H, 5.40; N, 6.83Calculated: C, 64.38; H, 5.40; N, 6.83

실측치 : C, 64.39; H, 5.49; N, 6.71Found: C, 64.39; H, 5.49; N, 6.71

[실시예 25]Example 25

7-메틸-5-니트로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 219㎎을 실시예 22와 같이 접촉촉매 환원시켜 에탄올-물로부터 재결정하여 황색침상 결정인 5-아미노-7-메틸스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 74㎎을 얻는다. 융점은 138-141℃219 mg of 7-methyl-5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one was catalytically reduced in the same manner as in Example 22 and recrystallized from ethanol-water to give a yellow needle. 74 mg of 5-amino-7-methylspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as a crystal was obtained. Melting Point is 138-141 ℃

원소분석치, C11H11O2N로서Elemental Analysis Value, as C 11 H 11 O 2 N

계산치 : C, 69.82; H, 5.86; N, 7.40Calculated: C, 69.82; H, 5.86; N, 7.40

실측치 : C, 69.66; H, 5.71; N, 7.43Found: C, 69.66; H, 5.71; N, 7.43

[실시예 26]Example 26

5-7-니트로스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 250㎎, 산화백금 50㎎ 및 에탄올 20㎖를 수소기류인, 대기압하에서 1.25시간 동안 교반한다. 반응액에 옥살산을 가하고 촉매를 여과한다. 여과액을 감압하에서 농축시켜 약 3㎖로 만든다. 에테르를 가해 석출된 분만을 여과하여 취한다. 분말을 에탄올에 용해시키고 활성탄으로 탈색시킨 후에 에테르를 가하여 석출된 분말을 여과해서 취하여 5,7-디아미노스피로[벤조[b]푸란-(2(3H),1'-시클로프로판]-3-온. 1/2옥살산염. 1 수화물의 황갈색 분말을 얻는다.5-7-nitrospiro [benzo [b] furan-2 (3H), 250 mg of 1'-cyclopropane] -3-one, 50 mg of platinum oxide and 20 ml of ethanol were stirred under hydrogen atmosphere at atmospheric pressure for 1.25 hours do. Oxalic acid is added to the reaction solution and the catalyst is filtered off. The filtrate is concentrated under reduced pressure to about 3 ml. Only ether was added and precipitated was filtered off. The powder was dissolved in ethanol, decolorized with activated charcoal, ether was added, and the precipitated powder was collected by filtration to obtain 5,7-diaminospiro [benzo [b] furan- (2 (3H), 1'-cyclopropane] -3-. One-half oxalate to yield a tan powder of monohydrate.

원소분석치, C10H10O2N21/2(COOH)2·H2O로서Elemental analysis, C 10 H 10 O 2 N 2 1/2 (COOH) 2 · H 2 O as

계산치 : C, 52.17; H, 5.17; N, 11.06Calculated: C, 52.17; H, 5. 17; N, 11.06

실측치 : C, 52.12; H, 4.69; N, 10.87Found: C, 52.12; H, 4.69; N, 10.87

위의 옥살산 대신에 염산을 쓰면 5,7-디아미노스피로[벤조[b]푸란-(2(3H),1'-시클로프로판]-3-온 염산염. 1수화물을 얻게 된다. 이때 융점은 300℃이상Using hydrochloric acid instead of oxalic acid gives 5,7-diaminospiro [benzo [b] furan- (2 (3H), 1'-cyclopropane] -3-one hydrochloride monohydrate, with a melting point of 300 Above ℃

원소분석치, C10H10O2N2·HCl·H2O로서Elemental Analysis Value, as C 10 H 10 O 2 N 2 HClH 2 O

계산치 : C, 49.08; H, 5.35; N, 11.45Calculated: C, 49.08; H, 5. 35; N, 11.45

실측치 : C, 48.80; H, 5.13; N, 11.64Found: C, 48.80; H, 5.13; N, 11.64

[실시예 27]Example 27

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(1.35g)의 피리딘(13.5㎖) 용액에 얼음 냉가하에서 카르보벤질옥시클로라이드(30% 톨루엔, 7g)를 가하고 그 혼합물을 한시간 동안 저어준다. 반응혼합물을 얼음-염산(14㎖)에 붓고 초산에틸로 추출하여 추출액을 물로씻고 건조 농축시켜 용매를 제거한다. 잔유물을 에탄올로부터 재결정하여 담황색 침상결정인 5-벤질 옥시카르보닐아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 1.57g을 얻는다. 융점은 118-119℃Carbobenzyloxychloride (30% toluene) under ice cold in a pyridine (13.5 ml) solution of 5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.35 g) 7 g) is added and the mixture is stirred for 1 hour. The reaction mixture was poured into ice-hydrochloric acid (14 ml), extracted with ethyl acetate, the extract was washed with water and concentrated to dryness to remove the solvent. The residue is recrystallized from ethanol to obtain 1.57 g of pale yellow acicular crystal 5-benzyl oxycarbonylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one. Melting Point is 118-119 ℃

이 생성물의 아세톤(30㎖)용액에 수산화칼륨분말(0.57g)과 오오드메틸(1㎖)을 가하고 얼음냉각하에서 30분간 교반한 다음 실온에서 4시간 더 교반해준다. 반응혼합물에 묽은 염산을 가하고 초산에틸로 추출한다. 추출액을 물로 씻고 건조시킨 후 감압하에서 증류시켜 용매를 제거한다. 잔류물을 실리카겔 관크로마토그래피에 붙이고 클로로포름 용출화분을 에탄올로부터 재결정하여 무색침상 결정인 5-(N-벤질옥시카르보닐-N-메틸아미노)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 1.44g을 얻는다. 융점은 79-81℃Potassium hydroxide powder (0.57 g) and iomethyl (1 ml) are added to the acetone (30 ml) solution of this product, stirred for 30 minutes under ice cooling, and further stirred at room temperature for 4 hours. Dilute hydrochloric acid is added to the reaction mixture, which is extracted with ethyl acetate. The extract is washed with water, dried and distilled under reduced pressure to remove the solvent. The residue was subjected to silica gel column chromatography and the chloroform eluted fraction was recrystallized from ethanol to give 5- (N-benzyloxycarbonyl-N-methylamino) spiro [benzo [b] furan-2 (3H), 1 as a colorless needle. 1.44 g of '-cyclopropane] -3-one are obtained. Melting Point is 79-81 ℃

이 생성물을 메탄올(129㎖)에 용해시키고 5% 팔라듐-탄소의 존재하, 수소기류안에서 30분간 교반한다. 촉매를 여과하여 제거하고 그 여과액을 감압하에서 농축시키고 잔류물을 에탄올에 용해시키고 염산-디에틸에테르를 가하여 황색 침상결정인 5-메틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 염산염을 얻는다. 융점은 141-144℃This product is dissolved in methanol (129 mL) and stirred for 30 minutes in a hydrogen stream in the presence of 5% palladium-carbon. The catalyst was filtered off and the filtrate was concentrated under reduced pressure, and the residue was dissolved in ethanol and hydrochloric acid-diethyl ether was added to give the yellow acicular crystal 5-methylaminospiro [benzo [b] furan-2 (3H), 1 '-Cyclopropane] -3-one hydrochloride is obtained. Melting Point is 141-144 ℃

원소분석치, C11H11O2N·HCl·1/2H2O로서Elemental Analysis Value, as C 11 H 11 O 2 NHCl1 / 2H 2 O

계산치 : C, 56.29; H, 5.58; N, 5.97Calculated: C, 56.29; H, 5.58; N, 5.97

실측치 : C, 56.38; H, 5.15; N, 6.07Found: C, 56.38; H, 5. 15; N, 6.07

[실시예 28]Example 28

5-아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온(1.75g)과 37% 포르말린(14㎖)을 아세토니트릴을 용해시켜 얼음 냉각하에서 수소화시아붕소 리듐(1.52g)을 소량씩 가한다. 실온에서 그 혼합물을 40분간 저어준 다음 초산을 가해 중성으로 하고, 2.5시간 더 저어준다. 용매를 감압하에서 증류시키고 잔류물에 수산화나트륨 수용액을 가하고 클로로포름으로 추출한다. 추출액을 물로 씻고 건조, 농축시켜서 용매를 제거하고 잔류물을 실리카겔 크로마토그래피에 붙여 클로로포름으로 용출한 화분에다 염산-디에틸에테르를 가하여 에탄올로부터 재결정하면 연산 갈색의 침상결정인 5-디메틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 염산염 0.546g을 얻게 된다. 융점은 136-140℃5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.75 g) and 37% formalin (14 mL) were dissolved in acetonitrile and boron hydride under ice cooling Lithium (1.52 g) is added in small portions. Stir the mixture at room temperature for 40 minutes, add acetic acid to neutral, and stir another 2.5 hours. The solvent is distilled off under reduced pressure, and an aqueous sodium hydroxide solution is added to the residue, followed by extraction with chloroform. The extract was washed with water, dried and concentrated to remove the solvent, and the residue was added to silica gel chromatography. The residue was eluted with chloroform and hydrochloric acid-diethyl ether was added and recrystallized from ethanol to give 5-dimethylaminospiro [benzo]. 0.546 g of [b] furan-2 (3H), 1'-cyclopropane] -3-one hydrochloride is obtained. Melting Point is 136-140 ℃

NMR(D2O)δ : 1.67(2H,m,CH2), 1.93(2H,m,CH2), 3.37(6H,s,CH3), 7.43(1H,d, 방향족환 H), 7.93(2H,m, 방향족환 H).NMR (D 2 O) δ: 1.67 (2H, m, CH 2 ), 1.93 (2H, m, CH 2 ), 3.37 (6H, s, CH 3 ), 7.43 (1H, d, aromatic ring H), 7.93 (2H, m, aromatic ring H).

원소분석치, C12H13O2N·HCl로서Elemental Analysis Value, as C 12 H 13 O 2 N · HCl

계산치 : C, 60.13; H, 5.89; N, 5.85Calculated: C, 60.13; H, 5.89; N, 5.85

실측치 : C, 60.19; H, 5.72; N, 6.00Found: C, 60.19; H, 5.72; N, 6.00

[실시예 29]Example 29

5-니트로스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 35g, 37% 포르말린 60㎖, 초산 30㎖, 산화백금 3g 및 에탄올 500㎖의 혼합물을 수소압 20kg/cm2로써 실온하에서 환원시킨다. 수소흡수가 정지된 후 촉매를 여과하여 제거하고 여과액을 감압하에서 용출한다. 농축물을 클로로포름에 용해시켜 2N의 수산화 나트륨과 이어서 물로 씻어내고 건조시킨다. 클로로포름을 감압하에서 증발시켜 제거하고 얻은 기름상의 물질을 에탄올로부터 재결정시켜 황색 입방체 결정인 5-디메틸다미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 26g을 얻는다. 융점은 96.5-97.5℃A mixture of 35 g of 5-nitrospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one, 60 ml of 37% formalin, 30 ml of acetic acid, 3 g of platinum oxide and 500 ml of ethanol was subjected to hydrogen pressure. Reduce at room temperature with 20 kg / cm 2 . After hydrogen absorption ceases, the catalyst is filtered off and the filtrate is eluted under reduced pressure. The concentrate is dissolved in chloroform, washed with 2N sodium hydroxide followed by water and dried. Chloroform was removed by evaporation under reduced pressure, and the oily substance was recrystallized from ethanol to give yellow cube crystal 5-dimethyldaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one. Get Melting Point is 96.5-97.5 ℃

원소분석치, C12H13O2N로서Elemental Analysis Value, as C 12 H 13 O 2 N

계산치 : C, 70.91; H, 6.45; N, 6.89Calculated: C, 70.91; H, 6. 45; N, 6.89

실측치 : C, 71.06; H, 6.39; N, 6.71Found: C, 71.06; H, 6.39; N, 6.71

[실시예 30]Example 30

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(1.75g)과 아세트알데히트(3㎖)를 메탄올(105㎖)에 녹이고 그 메탄올성 용액을 산화백금 존재하, 수소기류안에서 22시간 동안 저어준다. 촉매를 여과하여 제거한 후 용매를 증발시켜 버리고 잔류물을 실리카겔 관 크로마토그래피에 붙여 사염화탄소-초산에틸(10 : 1)로서 용출한다.5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.75 g) and acetaldehyde (3 mL) were dissolved in methanol (105 mL) and the methanolic solution Is stirred for 22 hours in the presence of platinum oxide in a hydrogen stream. The catalyst is filtered off, the solvent is evaporated off and the residue is subjected to silica gel column chromatography to elute as carbon tetrachloride-ethyl acetate (10: 1).

제1화분을 염화수소로 포화된 에테르로서 염산염을 만들고 에탄올-에테르로부터 재결정하면 담황색의 침상결정인 5-디메틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.86g을 얻게 된다. 융점은 172-176℃Hydrochloride was prepared as ether saturated with hydrogen chloride and the first pot was recrystallized from ethanol ether to give 5-dimethylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3- as a pale yellow needle. You get 0.86g. Melting Point is 172-176 ℃

원소분석치, C14H17O2N·HCl로서Elemental Analysis Value, as C 14 H 17 O 2 N · HCl

계산치 : C, 62.80; H, 6.78; N, 5.23Calculated: C, 62.80; H, 6. 78; N, 5.23

실측치 : C, 62.78; H, 6.85; N, 5.10Found: C, 62.78; H, 6. 85; N, 5.10

제2화분을 염화수소로 포화된 에테르로서 염산염을 만들고 에탄올-에테르로부터 재결정하면 담황색의 침상결정인 5-에틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온. 염산염. 1/4 수화물 0.129g을 얻게 된다. 융점은 155-160℃The second pot is made of hydrochloride as ether saturated with hydrogen chloride and recrystallized from ethanol-ether to give 5-ethylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3- as a pale yellow needle. On. Hydrochloride. You get 0.129 g of 1/4 hydrate. Melting Point is 155-160 ℃

원소분석치, C12H13O2N·HCl·1/4 H2O로서Elemental Analysis Value, as C 12 H 13 O 2 NHCl, 1/4 H 2 O

계산치 : C, 59.02; H, 5.98; N, 5.73Calculated: C, 59.02; H, 5.98; N, 5.73

실측치 : C, 58.94; H, 5.86; N, 5.73Found: C, 58.94; H, 5.86; N, 5.73

[실시예 31]Example 31

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 (3.0g), 1,4-디보로모부탄(3.7g), 탄산수소나트륨(2.89g) 및 N,N-디메틸 포름아미드(150㎖)의 혼합액을 1시간동안 가열 환류한다. 반응액을 물로 희석시키고 초산에틸로 추출한다. 추출액을 물로 씻고 건조, 농축시켜 용매를 제거하고 잔류물을 실리카겔 크로마토그래피에 붙인다. 클로로포름으로 용출하는 제1화분을 감압하에 증류시켜서 황색결정(1.74g)을 얻는다. 염산-디에틸에테르를 가하여 에탄올로부터 재결정 시키면 황색침상결정인 5-(1-피롤리디닐)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 염산염을 얻게 된다. 융점은 136℃5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (3.0 g), 1,4-diboromobutane (3.7 g), sodium hydrogencarbonate (2.89 g) And a mixture of N, N-dimethyl formamide (150 mL) was heated to reflux for 1 hour. The reaction solution is diluted with water and extracted with ethyl acetate. The extract is washed with water, dried and concentrated to remove the solvent and the residue is subjected to silica gel chromatography. The first elution with chloroform is distilled off under reduced pressure to give yellow crystals (1.74 g). Recrystallization from ethanol by addition of hydrochloric acid-diethyl ether gave yellow needle crystal 5- (1-pyrrolidinyl) spiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one hydrochloride. do. Melting Point is 136 ℃

원소분석치, C14H15O2N·HCl로서Elemental Analysis Value, as C 14 H 15 O 2 N · HCl

계산치 : C, 63.27; H, 6.07; N, 5.27Calculated: C, 63.27; H, 6.07; N, 5.27

실측치 : C, 63.26; H, 6.10; N, 5.26Found: C, 63.26; H, 6. 10; N, 5.26

[실시예 32]Example 32

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 (2.62g), 비스(2-요오드에틸)에테르(5.4g), 탄산수소나트륨(3.75g)의 N,N-디메틸 포름아미드(150㎖)의 현탁액을 120-140℃에서 2.5시간동안 저어준다. 반응액을 물에 붓고 초산에틸로 추출한다. 추출물을 물로 씻고 건조시켜 증발에 의해서 용매를 제거한다. 잔류물을 실리카겔 관크로마토그래피에 붙이고 클로로포름-에탄올(99 : 1)로 용출한 화분을 감압하에서 용매를 증발, 농축시켜서 황색결정(1.12g)을 얻는다. 여기에 염산-에테르를 가하고 에탄올-에테르로부터 재결정시키면 담갈색 침상결정인 5모르폴리노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 염산염 0.927g을 얻게 된다. 융점은 128-131℃5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (2.62 g), bis (2-iodoethyl) ether (5.4 g), sodium hydrogencarbonate (3.75 g A suspension of N, N-dimethyl formamide (150 mL) is stirred at 120-140 ° C. for 2.5 hours. The reaction solution is poured into water and extracted with ethyl acetate. The extract is washed with water and dried to remove the solvent by evaporation. The residue was attached to silica gel column chromatography, and the flowerpot eluted with chloroform-ethanol (99: 1) was evaporated and concentrated to give a yellow crystal (1.12 g) under reduced pressure. When hydrochloric acid-ether is added thereto and recrystallized from ethanol-ether, 0.927 g of 5-morpholinospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one hydrochloride is obtained as a light brown needle. . Melting point is 128-131 ℃

원소분석치, C14H15O3N·HCl로서Elemental Analysis Value, as C 14 H 15 O 3 N · HCl

계산치 : C, 59.68; H, 5.73; N, 4.97Calculated: C, 59.68; H, 5.73; N, 4.97

실측치 : C, 59.59; H, 5.60; N, 4.95Found: C, 59.59; H, 5. 60; N, 4.95

[실시예 33]Example 33

5-아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온(1.75g)을 N-벤질-β,β'-디요오드 디에틸아민(6.8g), 탄산수소나트륨(4g)과 실시예 32와 같은 방법으로 반응시켜 황색침상 결정인 5-(4-벤질-1-피페라지닐)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.831g을 얻게 된다.5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.75 g) was converted to N-benzyl-β, β'-diiodine diethylamine (6.8 g), The reaction was carried out in the same manner as in Example 32 with sodium hydrogen carbonate (4 g) to give 5- (4-benzyl-1-piperazinyl) spiro [benzo [b] furan-2 (3H), 1′-cyclone as a yellow needle crystal. 0.831 g of propane] -3-one is obtained.

융점은 125-125.5℃Melting Point is 125-125.5 ℃

원소분석치, C21H22O2N2로서Elemental Analysis Value, as C 21 H 22 O 2 N 2

계산치 : C, 75.42; H, 6.63; N, 8.38Calculated: C, 75.42; H, 6.63; N, 8.38

실측치 : C, 75.26; H, 6.78; N, 8.41Found: C, 75.26; H, 6. 78; N, 8.41

[실시예 34]Example 34

5-아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온(1.74g)을 N-에틸-β,β'-디요오도 디에틸아민(5.84g), 탄산수소나트륨(4g)과 실시예 32와 같은 방법으로 반응시켜 황색 침상결정인 5-(4-에틸-1-피페라지닐)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온. 옥살산염. 1/2수화물을 얻는다. 융점은 175-179℃5-Aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.74 g) was converted to N-ethyl-β, β'-diiodo diethylamine (5.84 g). , Reacted with sodium hydrogen carbonate (4 g) in the same manner as in Example 32 to give 5- (4-ethyl-1-piperazinyl) spiro [benzo [b] furan-2 (3H), 1'- as a yellow needle. Cyclopropane] -3-one. Oxalate. Get 1/2 hydrate. Melting Point is 175-179 ℃

원소분석치, C16H20O2N2·C2H2O4·1/2H2O로서Elemental analysis value, C 16 H 20 O 2 N 2 · C 2 H 2 O 4 · 1 / 2H 2 O

계산치 : C, 58.20; H, 6.24; N, 7.54Calculated: C, 58.20; H, 6. 24; N, 7.54

실측치 : C, 58.00; H, 6.56; N, 7.24Found: C, 58.00; H, 6.56; N, 7.24

[실시예 35]Example 35

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 (0.875g)을 무수초산(7㎖), 초산(7㎖)로서 아세틸화시키고 그 아세틸화 생성물을 에탄올로부터 재결정시키면 5-아세틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.426g을 얻게 된다. 융점은 211-212℃5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.875 g) was acetylated as acetic anhydride (7 mL), acetic acid (7 mL) and its acetylation Recrystallization of the product from ethanol yielded 0.426 g of 5-acetylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one. Melting Point is 211-212 ℃

원소분석치, C12H11O3N로서Elemental Analysis Value, as C 12 H 11 O 3 N

계산치 : C, 66.35; H, 5.10; N, 6.45Calculated: C, 66.35; H, 5. 10; N, 6.45

실측치 : C, 66.37; H, 5.12; N, 6.38Found: C, 66.37; H, 5. 12; N, 6.38

[실시예 36]Example 36

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 (0.519g)을 피리딘(5㎖)에 용해된 용액에 얼음 냉각하에서 메탄술포닐 클로라이드(0.28㎖)를 가하여 저어준다. 반응액을 냉희석 염산에 붓고 초산에틸로 추출하여 그 추출액을 물로 씻고 건조, 농축시켜 용매를 제거한다. 잔류물을 에탄올로부터 재결정시키면 무색침상 결정인 5-메틸술포닐아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.38g을 얻게 된다. 융점은 152-154℃Methanesulfonyl chloride (0.28) under ice cooling in a solution of 5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.519 g) dissolved in pyridine (5 mL). ㎖) is added and stirred. The reaction solution was poured into cold dilute hydrochloric acid, extracted with ethyl acetate, the extract was washed with water, dried and concentrated to remove the solvent. Recrystallization of the residue from ethanol yielded 0.38 g of colorless needle crystal 5-methylsulfonylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one. Melting Point is 152-154 ℃

원소분석치, C11H11O4NS로서Elemental Analysis Value, C 11 H 11 O 4 NS

계산치 : C, 52.16; H, 4.38; N, 5.53; S, 12.66Calculated: C, 52.16; H, 4.38; N, 5.53; S, 12.66

실측치 : C, 52.20; H, 4.37; N, 5.32; S, 12.56Found: C, 52.20; H, 4. 37; N, 5. 32; S, 12.56

[실시예 37]Example 37

4-아세톡시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온에 10% 수산화나트륨 수용액을 넣어 실온에서 저어준다.10% aqueous sodium hydroxide solution is added to 4-acetoxyspiro [benzo [b] furan-2 (3H) and 1'-cyclopropane] -3-one and stirred at room temperature.

반응액 염산 산성으로 하고 초산에틸로 추출한다. 추출액을 물로 씻고 건조, 증류하여 용매를 제거하고 잔류물을 석유에테르로부터 재결정시키면 황색침상의 4-히드록시스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻게 된다. 융점은 100-109℃The reaction solution is acidified with hydrochloric acid and extracted with ethyl acetate. The extract was washed with water, dried and distilled to remove the solvent, and the residue was recrystallized from petroleum ether to give yellow needles of 4-hydroxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one. You get Melting Point is 100-109 ℃

원소분석치, C10H8O3로서Elemental Analysis Value, as C 10 H 8 O 3

계산치 : C, 68.18; H, 4.58;Calculated: C, 68.18; H, 4.58;

실측치 : C, 68.38; H, 4.42Found: C, 68.38; H, 4.42

[실시예 38]Example 38

6-아세틸아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 1.09g을 메탄올 50㎖에 용해시킨 용액에 수산화칼륨 0.8g을 가한 혼합물을 0.5시간동안 환류시킨다. 감압하에서 용매를 증발시키고 잔류물에 물을 가해 석출하는 결정을 여과해서 취하여 물로 씻고 건조시킨 후 그 결정을 메탄올로부터 재결정시키면 무색 프리즘상 결정의 아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻게 된다. 융점은 188-189℃To a solution of 1.09 g of 6-acetylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one in 50 ml of methanol, 0.8 g of potassium hydroxide was added to reflux for 0.5 hour. Let's do it. The solvent was evaporated under reduced pressure, water was added to the residue, and the precipitated crystals were collected by filtration, washed with water and dried. The crystals were recrystallized from methanol to give aminospiro [benzo [b] furan-2 (3H) as colorless prism crystals. 1'-cyclopropane] -3-one is obtained. Melting Point is 188-189 ℃

원소분석치, C10H9O2H로서Elemental analysis value, as C 10 H 9 O 2 H

계산치 : C, 68.56; H, 5.18; N, 8.00Calculated: C, 68.56; H, 5. 18; N, 8.00

실측치 : C, 68.34; H, 5.05; N, 7.88Found: C, 68.34; H, 5.05; N, 7.88

[실시예 39]Example 39

6-아세틸아미노-5-클로로스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(1.8g)을 실시예 38과 같은 방법으로 반응시키고 그 생성물을 메탄올로부터 재결정시키면 황색 판상결정의 6-아미노-5-클로로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 1.5g을 얻게 된다. 융점은 201℃6-acetylamino-5-chlorospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.8 g) was reacted in the same manner as in Example 38 and the product was reacted with methanol. Recrystallization gave 1.5 g of 6-amino-5-chlorospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as a yellow plate crystal. Melting Point is 201 ℃

원소분석치, C10H8O2NCl로서Elemental Analysis Value, C 10 H 8 O 2 NCl

계산치 : C, 57.29; H, 3.85; N, 6.68Calculated: C, 57.29; H, 3.85; N, 6.68

실측치 : C, 57.24; H, 3.74; N, 6.67Found: C, 57.24; H, 3. 74; N, 6.67

[실시예 40]Example 40

5-벤질옥시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(3.3g)을 메탄올안에서 접촉촉매 환원반응에 의하여 벤질이탈화시켜 담황색 침상결정인 5-히드록시스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 1.8g을 얻는다. 융점은 180-185℃5-Benzyloxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (3.3 g) was benzyl derivatized by catalytic catalytic reduction in methanol to give a pale yellow acicular crystal. 1.8 g of hydroxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one are obtained. Melting Point is 180-185 ℃

원소분석치, C10H8O3로서Elemental Analysis Value, as C 10 H 8 O 3

계산치 : C, 68.18; H, 4.58Calculated: C, 68.18; H, 4.58

실측치 : C, 68.12; H, 4.44Found: C, 68.12; H, 4.44

[실시예 41]Example 41

4-히드록시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(0.176g), 탄산칼륨(0.276g), β-디에틸아미노에틸 클로라이드(0.215g) 및 N,N-디메틸포름아미드(5㎖)의 혼합액을 실온에서 3시간동안 저어준다. 반응혼합액을 물로 희석시키고 초산에틸로서 추출시킨다. 추출액을 물로 씻고 건조, 증류시켜서 용매를 제거하고 잔류물을 실리카겔 관 크로마토그래피에 붙여 클로로포름으로서 용출한다. 생성물을 염산-포화디에틸에테르와 반응시켜 결과의 염산염을 에탄올-디에틸에테르로부터 재결정시키면 무색침상결정인 4-(2-디에틸아미노에틸옥시)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온. 염산염 0.221g을 얻게 된다. 융점은 160-168℃4-hydroxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.176 g), potassium carbonate (0.276 g), β-diethylaminoethyl chloride (0.215 g) And a mixture of N, N-dimethylformamide (5 ml) at room temperature for 3 hours. The reaction mixture is diluted with water and extracted as ethyl acetate. The extract is washed with water, dried and distilled to remove the solvent and the residue is subjected to silica gel column chromatography to elute as chloroform. The product was reacted with hydrochloric acid-saturated diethyl ether to recrystallize the resulting hydrochloride from ethanol-diethyl ether to give 4- (2-diethylaminoethyloxy) spiro [benzo [b] furan-2 (3H) as a colorless needle. , 1'-cyclopropane] -3-one. You get 0.221 g of hydrochloride. Melting Point is 160-168 ℃

원소분석치, C16H21O3N·HCl로서Elemental analysis value, C 16 H 21 O 3 N · HCl

계산치 : C, 61.63; H, 7.11; N, 4.49Calculated: C, 61.63; H, 7. 11; N, 4.49

실측치 : C, 61.38; H, 7.23; N, 4.38Found: C, 61.38; H, 7. 23; N, 4.38

[실시예 42]Example 42

5-히드록시스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(1.06g)을 실시예 41과 같은 방법으로 반응시켜 무색유상의 5-(2-디에틸아미노에틸옥시)스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온을 얻는다.5-hydroxyspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (1.06 g) was reacted in the same manner as in Example 41 to give a colorless oily 5- (2-di Ethylaminoethyloxy) spiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one is obtained.

핵자기공명스펙트럼(중클로로포름중의 δ값) : 1.07(6H, t,CH3) 1.63(4H,m,2',3'-CH2), 2.64(4H,q,NCH2CH3), 2.88(2H,t,NCH2CH2O), 4.04(2H,t,CH2O), 6.95-7.40(3H,m, 방향족환 H)Nuclear magnetic resonance spectrum (δ value in heavy chloroform): 1.07 (6H, t, CH 3 ) 1.63 (4H, m, 2 ', 3'-CH 2 ), 2.64 (4H, q, NCH 2 CH 3 ), 2.88 ( 2H, t, NCH 2 CH 2 O), 4.04 (2H, t, CH 2 O), 6.95-7.40 (3H, m, aromatic ring H)

[실시예 43]Example 43

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(0.747g)과 탄산칼슘(0.47g)을 사염화탄소(20㎖)와 염화메틸렌(5㎖)의 혼합물속에 현탁시킨다. 그 현탁액을 -17℃로 냉각시키고 브롬(0.22㎖)을 적하한후, 45분간 저어준다. 그 반응혼합물을 얼음물에 붓고 초산에틸로써 추출하여, 추출물을 물로 씻고 건조시켜 용매를 증발시킨다. 잔류물을 에탄올-물로부터 재결정시켜서 황색침상 결정인 5-아미노-4-브로모스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.6g을 얻는다.5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.747 g), calcium carbonate (0.47 g), carbon tetrachloride (20 mL) and methylene chloride (5 mL) Suspended in a mixture of. The suspension is cooled to -17 ° C, bromine (0.22 ml) is added dropwise, and the mixture is stirred for 45 minutes. The reaction mixture is poured into iced water, extracted with ethyl acetate, the extract is washed with water and dried to evaporate the solvent. The residue is recrystallized from ethanol-water to give 0.6 g of yellow needle crystal 5-amino-4-bromospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one.

융점은 167-170℃Melting Point is 167-170 ℃

원소분석치, C10H8O2NBr로서Elemental analysis value, as C 10 H 8 O 2 NBr

계산치 : C, 47.27; H, 3.19; N, 5.51Calculated: C, 47.27; H, 3. 19; N, 5.51

실측치 : C, 47.48; H, 3.12; N, 5.64Found: C, 47.48; H, 3. 12; N, 5.64

[실시예 44]Example 44

5-디메틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온(0.455g)과 탄산칼슘(0.246g)의 사염화탄소(10㎖) 현탁액을 실시예 43과 같은 방법으로 반응시켜 감색침상 결정인 4-브로모-5-디메틸아미노스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.213g을 얻는다. 융점은 79-81℃A suspension of carbon tetrachloride (10 ml) of 5-dimethylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.455 g) and calcium carbonate (0.246 g) was prepared in Example 43. The reaction was carried out in the same manner to obtain 0.213 g of 4-bromo-5-dimethylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one as a dark needle. Melting Point is 79-81 ℃

원소분석치, C12H12O2NBr로서Elemental Analysis Value, as C 12 H 12 O 2 NBr

계산치 : C, 51.08; H, 4.29; N, 4.97Calculated: C, 51.08; H, 4. 29; N, 4.97

실측치 : C, 50.87; H, 4.13; N, 5.03Found: C, 50.87; H, 4.13; N, 5.03

[실시예 45]Example 45

5-아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(0.181g)과 피리딘(0.083㎖)의 테트라히드로푸란(5㎖) 용액을 -17℃로 냉각시키고 종래의 방법으로 제조한 요오드벤젠 디클로라이드(0.282g)의 테트라히드로푸란(1.15㎖) 용액을 50분이상 적하하여 그대로 1시간동안 저어준다. 반응혼합물을 얼음물에 붓고 초산에틸로써 추출하여 그 추출물을 물로 씻고 건조시켜 용매를 증발시키고, 잔류물을 관크로마토그래피에 붙인다. 클로로포름으로부터 용출되는 제1화분을 감압하에서 농축시켜 용매를 제거하여 황색결정인 5-아미노-4-클로로스피로[벤조[b]푸란-2(3H),1'-시클로프로판]-3-온 0.038g을 얻는다.A tetrahydrofuran (5 mL) solution of 5-aminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one (0.181 g) and pyridine (0.083 mL) to -17 ° C. After cooling, a tetrahydrofuran (1.15 mL) solution of iodinebenzene dichloride (0.282 g) prepared by a conventional method is added dropwise for 50 minutes or more, and stirred for 1 hour as it is. The reaction mixture is poured into iced water, extracted with ethyl acetate, the extract is washed with water and dried to evaporate the solvent, and the residue is subjected to column chromatography. The first elution eluted from chloroform was concentrated under reduced pressure to remove the solvent. Yellow amino acid 5-amino-4-chlorospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one 0.038 get g

매스스펙트럼 : C12H12O2NCl, 분자이온피크(209)Mass spectrum: C 12 H 12 O 2 NCl, molecular ion peak (209)

[조제예][Preparation Example]

본 발명 화합물(1)을 이를 테면 항궤양제로 사용할 때는 예를 들자면 다음과 같은 처방에 의하여 쓸수가 있다.For example, when the compound (1) of the present invention is used as an anti-ulcer agent, for example, it can be used by the following prescription.

1. 정제1. Tablet

(1) 5-아세틸스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온 50g(1) 50 g of 5-acetylspiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one

(2) 락토오스(유당) 50g(2) 50 g lactose (lactose)

(3) 옥수수 전분 29g(3) 29 g of corn starch

(4) 스테아린산 마그네슘 100정 130g(4) 130 g of magnesium stearate 100 tablets

(1), (2) 및 17g의 옥수수전분을 혼합하여 7g의 옥수수전분에서 만든 풀과 함께 과립화하여 이 과립에 5g의 옥수수전분과 (4)를 가하여 이 혼합물을 압축정제기로 압축하여 정제 1정당(1)을 50㎎ 함유하는 직경 7㎜의 정제 1000개를 제조한다.(1), (2) and 17 g of corn starch are mixed and granulated together with the paste made from 7 g of corn starch, and 5 g of corn starch and (4) are added to the granules, and the mixture is compressed with a compressed tablet and purified. 1000 tablets of 7 mm in diameter containing 50 mg of sugar (1) were prepared.

2. 캡슈울제2. Capshuulje

(1) 5-디메틸아미노스피로[벤조[b]푸란-2(3H), 1'-시클로프로판]-3-온(1) 5-dimethylaminospiro [benzo [b] furan-2 (3H), 1'-cyclopropane] -3-one

50g50 g

(2) 락토오스 50g(2) 50 g of lactose

(3) 셀룰로오즈 미세분말 29g(3) 29 g of cellulose fine powder

(4) 스테아린산 마그네슘 1000캡슈울 200g(4) Magnesium Stearate 1000capsule 200g

전 성분을 혼합하여 젤라틴 캡슈을 제3호(제8개정 일본약국방) 1000개를 충전하여 캡슈울 1개당(1)을 50㎎ 함유하는 캡슈울제를 제조한다.All ingredients are mixed to fill 1,000 gelatin caps with No. 3 (Eighth Amendment of Japan Pharmacopoeia), to prepare a capsule containing 50 mg (1) per capswool.

Claims (1)

본문에 상술한 바와 같이, 하기 일반식(Ⅱ)의 화합물을 탈탄산 반응시킴으로써 이루어지는 일반식(Ⅰ)의 스피로벤조푸란은 화합물의 제조방법.As described above in the text, the method for producing a spiro benzofuran compound of the general formula (I), which is obtained by decarboxylating a compound of the general formula (II) below.
Figure kpo00010
Figure kpo00010
상기 식중, 환 A는 벤젠환 또는 나프탈렌환을 나타내고 그 벤젠환 또는 나프탈렌환은 저급알킬기, 니트로기, 할로겐원자, 치환되어도 좋은 아미노기, 치환되어도 좋은 수산기, 아실기 및 술파모일기중 최소한 한개 이상으로 치환되어 있어도 좋다.In the above formula, Ring A represents a benzene ring or naphthalene ring, and the benzene ring or naphthalene ring is substituted with at least one of lower alkyl group, nitro group, halogen atom, optionally substituted amino group, optionally substituted hydroxyl group, acyl group and sulfamoyl group. You may be.
KR7803938A 1978-12-26 1978-12-26 Process for preparing spirobenzofuranone compounds KR810001073B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR7803938A KR810001073B1 (en) 1978-12-26 1978-12-26 Process for preparing spirobenzofuranone compounds
KR1019810002429A KR810001089B1 (en) 1978-12-26 1981-07-03 Process for preparing spirobenzofuranone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR7803938A KR810001073B1 (en) 1978-12-26 1978-12-26 Process for preparing spirobenzofuranone compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019810002429A Division KR810001089B1 (en) 1978-12-26 1981-07-03 Process for preparing spirobenzofuranone compounds

Publications (1)

Publication Number Publication Date
KR810001073B1 true KR810001073B1 (en) 1981-09-11

Family

ID=19209613

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7803938A KR810001073B1 (en) 1978-12-26 1978-12-26 Process for preparing spirobenzofuranone compounds

Country Status (1)

Country Link
KR (1) KR810001073B1 (en)

Similar Documents

Publication Publication Date Title
DK2324002T3 (en) Methods of making of sglt2 inhibitors
EP0264586B1 (en) Hydantoin derivatives for treating complications of diabetes
KR19990088113A (en) Fumagillol derivatives and preparation method thereof
US4584321A (en) 3-(3-Hydroxybutoxy)-1-butanol in pharmaceutical compositions
WO2001074820A1 (en) Novel derivatives and analogues of galanthamin
US4697005A (en) 1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
US4855422A (en) Process for the preparation of azoniaspironortropanol esters
KR810001073B1 (en) Process for preparing spirobenzofuranone compounds
US4774241A (en) Derivative of benzoquinonylphenyl alkanoic acid amide
KR870001281B1 (en) Process for preparing bicyclic benzo fused compounds
KR810001089B1 (en) Process for preparing spirobenzofuranone compounds
US4412071A (en) Antiatherosclerotic compositions
US4434295A (en) Anti-atherosclerotic 6,7-dihydro-7,7-disubstituted-khellin analogs
EP0270692A1 (en) Antiarrhythmic agent
EP0003084B1 (en) Spirobenzofuranone compounds, processes for their preparation and their use as medicines
KR860000200B1 (en) Process for preparing spiro compounds
US3407210A (en) Aminoethyl-benzofurans and derivatives thereof
EP0026000B1 (en) Spiro compounds, process for their preparation and pharmaceutical compositions containing them
US4293695A (en) Furonaphthyridine compounds
US4284644A (en) Spirobenzofuranone compounds
US4342779A (en) 7-Acetylspirobenzofuranone compound
JPH05339271A (en) Quinoline derivative or its salt
US4663445A (en) 1-fluoro, 4-fluoro, and 1,4-difluoro-2'-halo anthracycline antibiotics
EP0018830B1 (en) Spirobenzofuranones, their production and pharmaceutical compositions containing them
KR860000265B1 (en) Process for preparing spiro compounds